{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:56:18Z","timestamp":1763754978489,"version":"3.45.0"},"reference-count":21,"publisher":"Oncology Nursing Society (ONS)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.1188\/20.cjon.356-359","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T09:49:26Z","timestamp":1594979366000},"page":"356-359","source":"Crossref","is-referenced-by-count":0,"title":["Renal Cell Cancer Syndromes: Identification and Management of Patients and Families at Increased Risk"],"prefix":"10.1188","volume":"24","author":[{"given":"Melissa","family":"Paquin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Fasolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Arenas Valencia, C., Rodr\u00edguez L\u00f3pez, M.L., Cardona Barreto, A.Y., Garavito Rodr\u00edguez, E., & Arteaga D\u00edaz, C.E. (2017). Hereditary leiomyomatosis and renal cell cancer syndrome: Identification and clinical characterization of a novel mutation in the FH gene in a Colombian family. Familial Cancer, 16(1), 117\u2013122. https:\/\/doi.org\/10.1007\/s10689-016-9922-4","DOI":"10.1007\/s10689-016-9922-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Breuksch, I., Welter, J., Bauer, H.-K., Enklaar, T., Frees, S., Th\u00fcroff, J.W., . . . Brenner, W. (2018). In renal cell carcinoma the PTEN splice variant PTEN-D shows similar function as the tumor suppressor PTEN itself.\u00a0Cell Communication and Signaling,\u00a016, 35.","DOI":"10.1186\/s12964-018-0247-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Centini, R., Tsang, M., Iwata, T., Park, H., Delrow, J., Margineantu, D., . . . Iritani, B.M. (2018). Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation.\u00a0PLOS ONE,\u00a013(6), e0197973. https:\/\/doi.org\/10.1371\/journal.pone.0197973","DOI":"10.1371\/journal.pone.0197973"},{"key":"4","unstructured":"Colorectal Cancer Alliance. (n.d.). Who should be screened and when. https:\/\/bit.ly\/3245OQP"},{"key":"5","doi-asserted-by":"crossref","unstructured":"da Costa, W.H., Netto, G.J., & da Cunha, I.W. (2017). Urological cancer related to familial syndromes.\u00a0International Brazilian Journal of Urology,\u00a043(2), 192\u2013201. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0125","DOI":"10.1590\/s1677-5538.ibju.2016.0125"},{"key":"6","unstructured":"Eng, C. (2016). PTEN hamartoma tumor syndrome. GeneReviews\u00ae. Retrieved October 31, 2019, from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1488"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gossage, L., Murtaza, M., Slatter, A.F., Lichtenstein, C.P., Warren, A., Haynes, B., . . . Eisen, T. (2014). Clinical and pathological impact of\u00a0VHL, PBRM1, BAP1, SETD2, KDM6A, and\u00a0JARID1c\u00a0in clear cell renal cell carcinoma. Genes Chromosomes and Cancer, 53(1), 38\u201351. https:\/\/doi.org\/10.1002\/gcc.22116","DOI":"10.1002\/gcc.22116"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Gupta, S., Zhang, J., Milosevic, D., Mills, J.R., Grebe, S.K., Smith, S.C., & Erikson, L.A. (2017). Primary renal paragangliomas and renal neoplasia associated with pheochromocytoma\/paraganglioma: Analysis of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX) and transmembrane protein 127 (TMEM127). Endocrine Pathology, 28(3), 253\u2013268. https:\/\/doi.org\/10.1007\/s12022-017-9489-0","DOI":"10.1007\/s12022-017-9489-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Kallinikas, G., Habib, H., Tsimiliotis, D., Koutsokostas, E., & Bokor, B. (2017). Renal cell cancers: Unveiling the hereditary ones and saving lives\u2014A tailored diagnostic approach. International Urology and Nephrology, 49(9), 1507\u20131512. https:\/\/doi.org\/10.1007\/s11255-017-1625-8","DOI":"10.1007\/s11255-017-1625-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Leech, J.D., Lammers, S.H.T., Goldman, S., Auricchio, N., Bronson, R.T., Kwiatkowski, D.J., & Sahin, M. (2015). A vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas.\u00a0Molecular Cancer Research,\u00a013(3), 548\u2013555. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0178","DOI":"10.1158\/1541-7786.MCR-14-0178"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Lynch, H.T., Snyder, C.L., Shaw, T.G., Heinen, C.D., & Hitchins, M.P. (2015). Milestones of Lynch syndrome: 1895\u20132015. Nature Reviews Cancer, 15(3), 181\u2013194. https:\/\/doi.org\/10.1038\/nrc3878","DOI":"10.1038\/nrc3878"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Masoomian, B., Shields, J.A., & Shields, C.L. (2018). Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma.\u00a0Journal of Current Ophthalmology,\u00a030(2), 102\u2013109. https:\/\/doi.org\/10.1016\/j.joco.2018.02.005","DOI":"10.1016\/j.joco.2018.02.005"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Menko, F.H., Maher, E.R., Schmidt, L.S., Middelton, L.A., Aittom\u00e4ki, K., Tomlinson, I., . . . Linehan, W.M. (2014). Hereditary leiomyomatosis and renal cell cancer (HLRCC): Renal cancer risk, surveillance and treatment.\u00a0Familial Cancer,\u00a013(4), 637\u2013644. https:\/\/doi.org\/10.1007\/s10689-014-9735-2","DOI":"10.1007\/s10689-014-9735-2"},{"key":"14","unstructured":"National Cancer Institute. (2020). Genetics of kidney cancer (renal cell cancer) (PDQ\u00ae)\u2013Health professional version. https:\/\/www.cancer.gov\/types\/kidney\/hp\/kidney-genetics-pdq#_362_toc"},{"key":"15","unstructured":"National Comprehensive Cancer Network. (2019). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Kidney cancer [v.2.2020]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/kidney.pdf"},{"key":"16","unstructured":"National Institute of Neurological Disorders and Stroke. (2020). Tuberous sclerosis fact sheet. https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-She..."},{"key":"17","unstructured":"National Organization for Rare Disorders. (2018). Birt-Hogg-Dub\u00e9 syndrome. https:\/\/rarediseases.org\/rare-diseases\/birt-hogg-dube-syndrome"},{"key":"18","unstructured":"National Organization for Rare Disorders. (2019). Von Hippel-Lindau disease. https:\/\/rarediseases.org\/rare-diseases\/von-hippel-lindau-disease"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Skala, S., Dhanasekaran, S., & Mehra, M. (2018). Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): A contemporary review and practical discussion of the differential diagnosis for HLRCC-associated renal cell carcinoma. Archives of Pathology and Laboratory Medicine, 142(10), 1202\u20131215. https:\/\/doi.org\/10.5858\/arpa.2018-0216-RA","DOI":"10.5858\/arpa.2018-0216-RA"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Therkildsen, C., Joost, P., Lindberg, L.J., Ladelund, S., Smith-Hansen, L., & Nilbert, M. (2016). Renal cell cancer linked to Lynch syndrome: Increased incidence and loss of mismatch repair protein expression.\u00a0International Journal of Urology, 23(6), 528\u2013529. https:\/\/doi.org\/10.1111\/iju.13094","DOI":"10.1111\/iju.13094"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Ziada-Bouchaar, H., Sifi, K., Filali, T., Hammada, T., Satta, D., & Abadi, N. (2017). First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome. Familial Cancer, 16(1), 57\u201366. https:\/\/doi.org\/10.1007\/s10689-016-9917-1","DOI":"10.1007\/s10689-016-9917-1"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/24\/4\/renal-cell-cancer-syndromes-identification-and-management-patients-and-families-increased","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:10Z","timestamp":1763754610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/24\/4\/renal-cell-cancer-syndromes-identification-and-management-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1188\/20.cjon.356-359","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}